Please provide your email address to receive an email when new articles are posted on . Due to inconsistencies in interpretation and application, use of older or newly introduced lymph node maps may ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

NEW ORLEANS — January 31, 2026 — Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for ...

SAN ANTONIO -- Thoracic surgeons were fired up about minimum expectations for surgical lymph node assessment in conjunction with lung cancer resection during a debate at the Society of Thoracic ...

Incidence of non-metastatic extrathoracic lesions detected by whole-body FDG PET-CT imaging in patients with non-small-cell lung cancer Background: The aim of this study was to investigate the pattern ...

Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases. Lymph node dissection, the ...

Evaluation of the hilar and mediastinal lymph nodes is part of the surgical treatment of non-small cell lung cancer (NSCLC). It is also vital to the staging of lung cancer, which determines the need ...

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.

The process of staging lung cancer accurately plays a major role in establishing treatment options and predicting survival. Proper lung cancer staging demands a thorough understanding of TNM-8, which ...

Upon IAV infection, lung CD8⁺ tissue-resident memory T (TRM) cells upregulate residency-associated gene signatures but exhibit increased apoptosis. A subset of these cells undergoes CCR5–CCL5 ...